AxoGen Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
20,069.80
8,215.80
25,909.50
30,014.40
36,506.60
122,605
Total Accounts Receivable
1,893.70
2,872.30
4,783.00
8,052.20
11,064.70
15,321
Inventories
3,398.40
3,213.60
3,934.00
5,458.80
7,315.90
11,982
Other Current Assets
296.70
109.40
424.90
511.80
853.40
1,045
Total Current Assets
25,658.60
14,411.10
35,051.40
44,037.30
55,740.70
150,953
Net Property, Plant & Equipment
381.70
619.00
970.90
1,494.20
2,197.00
8,039
Intangible Assets
570.40
577.20
678.10
829.00
937.00
1,181
Other Assets
1,073.60
793.50
-
-
-
-
Total Assets
27,684.30
16,400.80
36,700.30
46,360.50
58,874.70
160,173
ST Debt & Current Portion LT Debt
-
-
-
4,045.90
4,735.00
Accounts Payable
2,083.90
2,431.20
2,106.10
4,418.70
3,238.00
Other Current Liabilities
14.10
14.10
1,603.20
2,616.70
5,745.80
Total Current Liabilities
2,098.10
2,445.30
3,709.20
11,081.40
13,718.70
Long-Term Debt
25,363.70
25,085.80
24,701.70
20,265.70
19,905.30
Other Liabilities
85.90
115.40
93.80
92.20
68.60
Total Liabilities
27,547.60
27,646.50
28,504.70
31,439.30
33,692.70
Common Equity (Total)
136.60
11,245.70
8,195.60
14,921.10
25,182.00
Total Shareholders' Equity
136.60
11,245.70
8,195.60
14,921.10
25,182.00
Total Equity
136.60
11,245.70
8,195.60
14,921.10
25,182.00
Liabilities & Shareholders' Equity
27,684.30
16,400.80
36,700.30
46,360.50
58,874.70

About AxoGen

View Profile
Address
13631 Progress Boulevard
Alachua Florida 32615
United States
Employees -
Website http://www.axogeninc.com
Updated 07/08/2019
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator.